A carregar...
Bile acid changes after high-dose ursodeoxycholic acid treatment in primary sclerosing cholangitis: relation to disease progression
High-dose (28-30mg/kg/day) ursodeoxycholic acid (UDCA) treatment improves serum liver tests in patients with primary sclerosing cholangitis (PSC) but does not improve survival and is associated with increased rates of serious adverse events. The mechanism for the latter undesired effect remains uncl...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2928060/ https://ncbi.nlm.nih.gov/pubmed/20564380 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/hep.23631 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|